BioNexus Gene Lab (BGLC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.20, -1.63% vs the prior close of $1.22.
- Volume 6.00K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BGLC dips 1.6% to $1.20, 4 down days in a row. Closed at $1.20, -1.63% vs the prior close of $1.22. Day range $1.20β$1.24, opened at $1.21.
BGLC daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β BGLC dips 1.6% to $1.20, 4 down days in a row
- Closed at $1.20, -1.63% vs the prior close of $1.22. Day range $1.20β$1.24, opened at $1.21.
- Volume was 6.00K shares, 0.7x its 50-day average of 8.65K.
- Price is -16.6% vs its 50-day average ($1.44) and -42.8% vs its 200-day average ($2.10).
- 52-week range $1.07β$5.89; today's close sits at 3% of that range, 79.6% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 β BGLC slides 3.1% to $1.22, 3 down days in a row
- Closed at $1.22, -3.10% vs the prior close of $1.26. Day range $1.19β$1.22, opened at $1.20.
- Volume was 4.20K shares, 0.5x its 50-day average of 8.65K β lighter than usual.
- Price is -15.7% vs its 50-day average ($1.45) and -42.2% vs its 200-day average ($2.11).
- 52-week range $1.07β$5.89; today's close sits at 3% of that range, 79.3% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 β BGLC slides 4.5% to $1.26
- Closed at $1.26, -4.55% vs the prior close of $1.32. Day range $1.24β$1.28, opened at $1.24.
- Volume was 1.10K shares, 0.1x its 50-day average of 8.80K β lighter than usual.
- Price is -13.4% vs its 50-day average ($1.45) and -40.8% vs its 200-day average ($2.13).
- 52-week range $1.07β$5.89; today's close sits at 4% of that range, 78.6% below the 52-week high.
Oct 13, 2026 β BGLC slides 5.0% to $1.32
- Closed at $1.32, -5.04% vs the prior close of $1.39. Day range $1.20β$1.33, opened at $1.33.
- Volume was 8.40K shares, 0.8x its 50-day average of 10.81K.
- Price is -9.6% vs its 50-day average ($1.46) and -38.4% vs its 200-day average ($2.14).
- 52-week range $1.07β$5.89; today's close sits at 5% of that range, 77.6% below the 52-week high.
Oct 12, 2026 β BGLC jumps 7.8% to $1.39
- Closed at $1.39, +7.75% vs the prior close of $1.29. Day range $1.27β$1.39, opened at $1.27.
- Volume was 18.60K shares, 1.7x its 50-day average of 10.64K.
- Price is -5.0% vs its 50-day average ($1.46) and -35.5% vs its 200-day average ($2.16).
- 52-week range $1.07β$5.89; today's close sits at 7% of that range, 76.4% below the 52-week high.
Oct 9, 2026 β BGLC jumps 3.3% to $1.29
- Closed at $1.29, +3.28% vs the prior close of $1.25. Day range $1.21β$1.29, opened at $1.21.
- Volume was 3.90K shares, 0.4x its 50-day average of 10.63K β lighter than usual.
- Price is -11.7% vs its 50-day average ($1.46) and -40.6% vs its 200-day average ($2.17).
- 52-week range $1.07β$5.89; today's close sits at 5% of that range, 78.1% below the 52-week high.
Oct 8, 2026 β BGLC slides 6.8% to $1.25
- Closed at $1.25, -6.79% vs the prior close of $1.34. Day range $1.25β$1.33, opened at $1.33.
- Volume was 1.10K shares, 0.1x its 50-day average of 12.47K β lighter than usual.
- Price is -14.6% vs its 50-day average ($1.46) and -42.8% vs its 200-day average ($2.18).
- 52-week range $1.07β$5.89; today's close sits at 4% of that range, 78.8% below the 52-week high.
Oct 7, 2026 β BGLC jumps 8.1% to $1.34 on 2.3x normal volume
- Closed at $1.34, +8.06% vs the prior close of $1.24. Day range $1.21β$1.36, opened at $1.33.
- Volume was 27.50K shares, 2.3x its 50-day average of 12.10K β unusually heavy trading.
- Price is -8.5% vs its 50-day average ($1.46) and -39.1% vs its 200-day average ($2.20).
- 52-week range $1.07β$5.89; today's close sits at 6% of that range, 77.2% below the 52-week high.
- SEC filings that day: 8-K.
Oct 6, 2026 β BGLC slides 3.1% to $1.24
- Closed at $1.24, -3.12% vs the prior close of $1.28. Day range $1.20β$1.27, opened at $1.21.
- Volume was 18.00K shares, 1.5x its 50-day average of 11.88K.
- Price is -15.3% vs its 50-day average ($1.46) and -44.0% vs its 200-day average ($2.21).
- 52-week range $1.07β$5.89; today's close sits at 4% of that range, 78.9% below the 52-week high.
Oct 5, 2026 β BGLC rises 0.8% to $1.28
- Closed at $1.28, +0.79% vs the prior close of $1.27. Day range $1.27β$1.31, opened at $1.28.
- Volume was 11.80K shares, 1.0x its 50-day average of 11.74K.
- Price is -12.7% vs its 50-day average ($1.47) and -42.5% vs its 200-day average ($2.23).
- 52-week range $1.07β$5.89; today's close sits at 4% of that range, 78.3% below the 52-week high.
Oct 2, 2026 β BGLC jumps 5.8% to $1.27
- Closed at $1.27, +5.83% vs the prior close of $1.20. Day range $1.25β$1.28, opened at $1.25.
- Volume was 2.50K shares, 0.2x its 50-day average of 11.75K β lighter than usual.
- Price is -13.7% vs its 50-day average ($1.47) and -43.3% vs its 200-day average ($2.24).
- 52-week range $1.07β$5.89; today's close sits at 4% of that range, 78.4% below the 52-week high.
BGLC latest news & SEC filings
Every SEC filing by or about BGLC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 3.02 β Sold unregistered shares.
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 Β· Form SCHEDULE 13D β Activist-style stake (13D)
Activist-style stake (13D) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $76.16K (prior year $2.26M) (-96.6% vs Jun 30, 2025)
- Net income: -$286.45K (prior year -$616.17K) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.12 (prior year -$0.34) (loss narrowed vs Jun 30, 2025)
Aug 7, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Jul 28, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Things to know before you trade BGLC
- How much it moves: over the last 20 sessions the average daily move was 3.94% (largest 8.1%). That is a volatile stock.
- Liquidity: about 10.21K shares (β$12.26K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.20 vs a range of $1.07β$5.89 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Apr 7, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 7, 2026; 10-Q Aug 14, 2026; 8-K Jul 28, 2026.
- Share count: 2.93M shares outstanding (Aug 14, 2026), +63.3% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Services-Medical Laboratories.
BGLC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.21 | 1.24 | 1.20 | 1.20 | 6.00K |
| Oct 15, 2026 | 1.20 | 1.22 | 1.19 | 1.22 | 4.20K |
| Oct 14, 2026 | 1.24 | 1.28 | 1.24 | 1.26 | 1.10K |
| Oct 13, 2026 | 1.33 | 1.33 | 1.20 | 1.32 | 8.40K |
| Oct 12, 2026 | 1.27 | 1.39 | 1.27 | 1.39 | 18.60K |
| Oct 9, 2026 | 1.21 | 1.29 | 1.21 | 1.29 | 3.90K |
| Oct 8, 2026 | 1.33 | 1.33 | 1.25 | 1.25 | 1.10K |
| Oct 7, 2026 | 1.33 | 1.36 | 1.21 | 1.34 | 27.50K |
| Oct 6, 2026 | 1.21 | 1.27 | 1.20 | 1.24 | 18.00K |
| Oct 5, 2026 | 1.28 | 1.31 | 1.27 | 1.28 | 11.80K |
| Oct 2, 2026 | 1.25 | 1.28 | 1.25 | 1.27 | 2.50K |
| Oct 1, 2026 | 1.28 | 1.43 | 1.20 | 1.20 | 40.80K |
| Sep 30, 2026 | 1.28 | 1.28 | 1.16 | 1.22 | 9.10K |
| Sep 29, 2026 | 1.37 | 1.40 | 1.27 | 1.27 | 15.00K |
| Sep 28, 2026 | 1.38 | 1.41 | 1.27 | 1.30 | 11.40K |
| Sep 25, 2026 | 1.43 | 1.47 | 1.25 | 1.39 | 6.00K |
| Sep 24, 2026 | 1.50 | 1.50 | 1.44 | 1.48 | 3.10K |
| Sep 23, 2026 | 1.45 | 1.47 | 1.45 | 1.47 | 3.30K |
| Sep 22, 2026 | 1.48 | 1.48 | 1.45 | 1.46 | 1.70K |
| Sep 21, 2026 | 1.53 | 1.54 | 1.47 | 1.50 | 10.70K |
About BioNexus Gene Lab
BioNexus Gene Lab (BGLC) is listed on the Nasdaq and classified by the SEC under βServices-Medical Laboratoriesβ. Its business address is in KUALA LUMPUR. State of incorporation: WY. Fiscal year ends December 31. SEC CIK 1737523.
BGLC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Abdul Hamid Muhammad Azrul Bin | Director | Aug 14, 2026 |
| Jook Yuen Low | Director | Aug 14, 2026 |
| Lee Su-Leng Tan | Chief Executive Officer | Aug 14, 2026 |
| Chee Keong Yap | Director | Aug 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Set Fui Chong | Chief Financial Officer | Aug 14, 2026 |
| Lee Su-Leng Tan | Chief Executive Officer | Aug 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BGLC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $7.42M | $-2.98M | β | $-1.84M |
| Dec 31, 2024 | $9.51M | $-1.60M | -0.09 | $-2.09M |
| Dec 31, 2023 | $9.77M | $-2.63M | -0.17 | $-1.82M |
| Dec 31, 2022 | $10.93M | $-355.97K | β | $551.82K |
| Dec 31, 2021 | $13.36M | $751.57K | β | $9.16K |
Latest balance sheet: total assets $8.73M, total liabilities $947.98K, cash $1.23M (as of Jun 30, 2026).
BGLC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BGLC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.